Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 13 Feb 2025

Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Berenice Anabel Silva
María Celeste Leal
María Isabel Farias
Agustín Nava
Daniela Inés Galván
Elmer Fernandez
Fernando Juan Pitossi
Carina Cintia Ferrari

Frontiers in Immunology

doi 10.3389/fimmu.2025.1505459

3,295 views

Correction

Published on 07 Feb 2025

Corrigendum: The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Femke Van Gaever
Fleur Mingneau
Sam Vanherle
Yasmine Driege
Mira Haegman
Elien Van Wonterghem
Junhua Xie
Roosmarijn E. Vandenbroucke
Jerome J. A. Hendriks
Rudi Beyaert

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562292

1,484 views

Case Report

Published on 06 Feb 2025

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

David Qixiang Chen
José Adalberto Inzunza Domínguez
Juan Manuel Valle Uzeta
Abhiram P. Pushparaj
Jonathan E. Dickinson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535782

19,783 views
2 citations

Original Research

Published on 06 Feb 2025

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers

in Multiple Sclerosis and Neuroimmunology

Xin Wang
Ruibin Zhao
Jiayu Fan
Chong Liu
Li Zhang
Huafang Yang
Weiyi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1534172

2,230 views

Original Research

Published on 05 Feb 2025

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration

in Multiple Sclerosis and Neuroimmunology

Lucas Stürzbecher
Hendrik Bartolomaeus
Theda U. P. Bartolomaeus
Sylvia Bolz
Andjela Sekulic
Marius Ueffing
Simon J. Clark
Nadine Reichhart
Sergio Crespo-Garcia
Nicola Wilck

Frontiers in Immunology

doi 10.3389/fimmu.2025.1520188

4,174 views
1 citation

Original Research

Published on 03 Feb 2025

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering

in Multiple Sclerosis and Neuroimmunology

Ryohei Yamamura
Makoto Kinoshita
Yoshiaki Yasumizu
Tomohiro Yata
Keigo Kihara
Daisuke Motooka
Naoyuki Shiraishi
Yasuko Sugiyama
Shohei Beppu
Hisashi Murata

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508977

4,072 views
2 citations

Original Research

Published on 03 Feb 2025

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

in Multiple Sclerosis and Neuroimmunology

Heinz Wiendl
Frederik Barkhof
Xavier Montalban
Anat Achiron
Tobias Derfuss
Andrew Chan
Suzanne Hodgkinson
Alexandre Prat
Letizia Leocani
Klaus Schmierer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512189

7,693 views
6 citations

Original Research

Published on 31 Jan 2025

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Vinzenz Fleischer
Tobias Brummer
Muthuraman Muthuraman
Falk Steffen
Milena Heldt
Maria Protopapa
Muriel Schraad
Gabriel Gonzalez-Escamilla
Sergiu Groppa
Stefan Bittner

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532660

4,014 views
4 citations

Case Report

Published on 31 Jan 2025

When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report

in Multiple Sclerosis and Neuroimmunology

Palash Kotak
Kashish Khurana
Sarang Raut
Saket Satyasham Toshniwal
Sourya Acharya

Frontiers in Immunology

doi 10.3389/fimmu.2025.1504967

2,797 views
1 citation

Correction

Published on 31 Jan 2025

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

in Multiple Sclerosis and Neuroimmunology

Sahithi Attaluri
Raghavendra Upadhya
Maheedhar Kodali
Leelavathi N. Madhu
Dinesh Upadhya
Bing Shuai
Ashok K. Shetty

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557065

1,160 views
1 citation

Original Research

Published on 30 Jan 2025

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators

in Multiple Sclerosis and Neuroimmunology

Michael Hecker
Brit Fitzner
Isis Ludwig-Portugall
Friederike Bohne
Edmar Heyland
Juliane Klehmet
Matthias Grothe
Matthias Schwab
Alexander Winkelmann
Stefanie Meister

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531447

3,743 views
2 citations

Review

Published on 29 Jan 2025

Immune conversations at the border: meningeal immunity in health and disease

in Multiple Sclerosis and Neuroimmunology

Preya U. Patel
Aryan Regmi
Angelina I. Dass
Olga L. Rojas

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531068

5,002 views
1 citation

Review

Published on 28 Jan 2025

Neutrophils, NETs and multiple sclerosis: a mini review

in Multiple Sclerosis and Neuroimmunology

Moyuan Quan
Huining Zhang
Xiaohong Deng
Huijia Liu
Yanqiu Xu
Xiujuan Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1487814

5,640 views
3 citations

Review

Published on 27 Jan 2025

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review

in Multiple Sclerosis and Neuroimmunology

Julie J. Paik
Lisa Christopher-Stine
Mikael Boesen
John A. Carrino
S. Peter Eggleton
Deborah Denis
Olga Kubassova

Frontiers in Immunology

doi 10.3389/fimmu.2025.1455867

5,594 views
1 citation

Case Report

Published on 24 Jan 2025

Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review

in Multiple Sclerosis and Neuroimmunology

Xuan Wu
Xiao-tian Xu
Lin Zhou
Kai Qiao
Chong-bo Zhao
Su-shan Luo

Frontiers in Immunology

doi 10.3389/fimmu.2025.1498847

4,386 views

Original Research

Published on 24 Jan 2025

Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension

in Multiple Sclerosis and Neuroimmunology

Yuyu Li
Mingming Sun
Xintong Xu
Biyue Chen
Xiyun Chen
Yuhang Wang
Quangang Xu
Huanfen Zhou
Shihui Wei

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516909

2,314 views

Original Research

Published on 23 Jan 2025

The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system

in Multiple Sclerosis and Neuroimmunology

Yue Zhou
Yutong Wu
Xiao Zhao
Lingxu Xu
Mingguang Sun
Zhaoyou Meng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515730

5,993 views
7 citations

Original Research

Published on 22 Jan 2025

Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review

in Multiple Sclerosis and Neuroimmunology

Runhua Bai
Li An
Wei Du
Zhiwei Wang
Xiaokun Qi
Jianguo Liu
Ming Ren
Yingxin Yu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519700

5,252 views
6 citations

Case Report

Published on 17 Jan 2025

Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report

in Multiple Sclerosis and Neuroimmunology

Xin Xue
Yingcun Bao
Yakun Yu
Qun Li
Mei Liu
Xiaoling Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517943

2,878 views
1 citation

Systematic Review

Published on 17 Jan 2025

Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Matteo Paolucci
Andrea Zini
Luana Morelli
Rocco Liguori
Maria Pia Giannoccaro

Frontiers in Immunology

doi 10.3389/fimmu.2025.1491880

2,062 views

Original Research

Published on 14 Jan 2025

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

J. Q. Alida Chen
Dennis D. Wever
Niamh B. McNamara
Morjana Bourik
Joost Smolders
Jörg Hamann
Inge Huitinga

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522381

4,591 views
5 citations

Case Report

Published on 14 Jan 2025

Case report: Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies

in Multiple Sclerosis and Neuroimmunology

Zhujun Mei
Jingguo Wang
Junling Wang
Xiaoni Liu
Bo Deng
Wenbo Yang
Xiang Zhang
Xiangjun Chen
Hai Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461024

2,565 views

Case Report

Published on 13 Jan 2025

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases

in Multiple Sclerosis and Neuroimmunology

Tianying Ma
Ying Zhu
Ruixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497398

3,098 views
2 citations

Case Report

Published on 10 Jan 2025

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G–seropositive neuromyelitis optica spectrum disorder: a case series report

in Multiple Sclerosis and Neuroimmunology

Hesham Abboud
Adnan Subei
Buse Sengul
Robert K. Shin
Paige Goulette
Rosemarie Walch
Jeanie Coté
Robert Pace
Ahmed Z. Obeidat
Lisa Ferayorni

Frontiers in Immunology

doi 10.3389/fimmu.2024.1526563

4,234 views
3 citations

1,480 articles

articles

Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis

Corrigendum: The phytohormone abscisic acid enhances remyelination in mouse models of multiple sclerosis

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis

When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators

Immune conversations at the border: meningeal immunity in health and disease

Neutrophils, NETs and multiple sclerosis: a mini review

The utility of muscle magnetic resonance imaging in idiopathic inflammatory myopathies: a scoping review

Distal muscle weakness as the main onset symptom in thymoma-associated myasthenia gravis: a case report and literature review

Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension

The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system

Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review

Severe Guillain-Barré syndrome with concurrent optic neuritis in a pediatric patient: a case report

Antibodies against neuronal surface antigens in acute stroke: a systematic review and meta-analysis

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis

Case report: Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies

Case report: Efgartigimod is a novel therapeutic option for ocular myasthenia gravis: a report of 2 cases

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G–seropositive neuromyelitis optica spectrum disorder: a case series report